Successful Business approach brings Opportunities in Senior Role
Derek Smith

News

Successful Business approach brings Opportunities in Senior Role

19 Feb, 2023

Published over 3 years ago. See the latest and most current information on News.

Since the beginning of the year, Derek Smith has been pursuing his position as Interim Chief Commercial Officer at Optimer® binders developer Aptamer Group. Having joined as Director of Global Sales in 2018 Mr Smith has progressed business across all three divisions of the York-based Group, including with a number of major pharmaceutical companies. He has previously held senior sales positions at various UK healthcare companies.

Dr Arron Tolley, Chief Executive Officer, commented: “Since joining Aptamer in 2018, Derek’s business acumen and commitment to his role have contributed to an impressive increase in our sales and revenue. Derek’s commercial mindset and dedication to the business will stand him in good stead as Interim Chief Commercial Officer. I look forward to working closely with him as we continue to pursue our strategic goals.”

Derek Smith added: “I’ve really enjoyed working at Aptamer over the past few years and being a part of its significant commercial progress, including playing a part in the Company’s public listing on AIM. As an increasing number of companies see the need for antibody alternatives, there is a clear opportunity for Aptamer to grow and strengthen its global customer base.”

More information online

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
DC’s July fireworks pollution spike exposes limits of annual air quality standards
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
EU methane transparency database now due in September 2026, European Commission confirms
Explore more Arrow
Chromatography Today
Chromatographic strategy reveals novel anti-diabetic diterpenes in roasted coffee
Explore more Arrow